HGF and lung cancer: We previously provided preclinical evidence that cytotoxic drug-resistant lung cancer cells secreted HGF and accelerated its resistance by increased expression of c-MET due to gene amplification, and that c-Met inhibitors restored cytotoxic drug sensitivity [26, 38].